Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...
Novo's new obesity therapy Wegovy is significantly expanding the obesity treatment market given its strong efficacy and is poised to remain a key drug in the market until patent expiration in 2032.
It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...
Clique para enviar por email a um amigo(abre em nova janela) Clique para compartilhar no Facebook(abre em nova janela) Compartilhe no Skype(abre em nova janela ...
$1.85B Expansion in Johnston County Doubling Workforce of 700 Collaborative Success for EDPNC, NCBiotech and State/Local Officials Each Biomanufacturing Job Creates Six Total Jobs Novo Nordisk, a key ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Um jovem com 19 anos, foi localizado e detido no dia de ontem, quinta-feira, em Valongo por coautoria de crimes graves de sequestro e roubo….
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback